Takeda Pharmaceutical Co (TSE:4502) Inventory Turnover: 0.29 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4502 Takeda Pharmaceutical Co Ltd TSE:4502
65 GF Score
Price 円5,318.00
GF Value 円4,537.90
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Takeda Pharmaceutical Co Inventory Turnover?

Takeda Pharmaceutical Co TSE:4502 -0.77% 65 Inventory Turnover is 0.29 as of Mar. 2026. GuruFocus rates TSE:4502 with a GF Score™ of 65/100 and a GF Value™ of 円4,537.90 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Takeda Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2026 was 円405,704 Mil. Takeda Pharmaceutical Co's Average Total Inventories for the quarter that ended in Mar. 2026 was 円1,401,906 Mil. Takeda Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.29.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Takeda Pharmaceutical Co's Days Inventory for the three months ended in Mar. 2026 was 315.31.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Takeda Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 1.28.

Takeda Pharmaceutical Co  (TSE:4502) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Takeda Pharmaceutical Co's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory =Average Total Inventories (Q: Mar. 2026 )/Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=1401906/405704*365 / 4
=315.31

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Takeda Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=1401906 / 1094541
=1.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Takeda Pharmaceutical Co Inventory Turnover Related Terms

Takeda Pharmaceutical Co Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Takeda Pharmaceutical Co's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co Inventory Turnover Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 1.35 1.30 1.30 1.20

Takeda Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.31 0.30 0.30 0.29
TSE:4502
65GF Score
Takeda Pharmaceutical Co Ltd TSE:4502
Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Takeda Pharmaceutical Co Inventory Turnover Calculation

Takeda Pharmaceutical Co's Inventory Turnover for the fiscal year that ended in Mar. 2026 is calculated as

Inventory Turnover (A: Mar. 2026 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Mar. 2026 ) / ((Total Inventories (A: Mar. 2025 ) + Total Inventories (A: Mar. 2026 )) / count )
=1571588 / ((1217349 + 1396620) / 2 )
=1571588 / 1306984.5
=1.20

Takeda Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover (Q: Mar. 2026 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Mar. 2026 ) / ((Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count )
=405704 / ((1407192 + 1396620) / 2 )
=405704 / 1401906
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Inventory Turnover →
What does a Inventory Turnover of 0.29 mean?
Takeda Pharmaceutical Co (TSE:4502) has a Inventory Turnover of 0.29 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Takeda Pharmaceutical Co and its competitors.
Is Takeda Pharmaceutical Co's Inventory Turnover too high?
Takeda Pharmaceutical Co's current Inventory Turnover is 0.29. Overall, Takeda Pharmaceutical Co has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Inventory Turnover compare to ZTS and UTHR?
Takeda Pharmaceutical Co's Inventory Turnover of 0.29 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory Turnover for a Drug Manufacturers company?
A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory Turnover mean?
A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Takeda Pharmaceutical Co and its competitors. Takeda Pharmaceutical Co's current Inventory Turnover is 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (TSE:4502) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,537.90, compared to a current price of 円5,318.00 — trading 17.2% above its estimated fair value. The current Inventory Turnover is 0.29. Takeda Pharmaceutical Co's overall GF Score™ is 65/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory Turnover calculated?
Inventory Turnover is calculated from a company's financial statements. For Takeda Pharmaceutical Co (TSE:4502), the current Inventory Turnover is 0.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Takeda Pharmaceutical Co (TSE:4502) Overvalued in 2026?

Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued. The current stock price of 円5,318.00 is trading 17.2% above its estimated GF Value™ of 円4,537.90. GuruFocus considers Takeda Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for TSE:4502:

  • Inventory Turnover: 0.29
  • GF Value™: 円4,537.90 vs. price of 円5,318.00 (17.2% above fair value)
  • GF Score™: 65/100 with 9 warning signs

No single metric tells the full story. See the TSE:4502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Takeda Pharmaceutical Co Business Description

Address 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
65GF Score

Get the complete analysis for TSE:4502

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円5,318.00
Price
円4,537.90
GF Value